Punjab to examine feasibility of new Hepatitis C drug
Chandigarh: Punjab Chief Minister Captain Amarinder Singh asked the health department to examine the feasibility of a new drug for treatment of Hepatitis-C, Epclusa in the state. The chief minister also directed the chief secretary to assess the success rate of the new drug through minute evaluation of the outcome of trials conducted by the AIIMS and the PGIMER to enable the state government to take a final decision.
The durg has been offered by the US-based Gilead Sciences, an official statement said. Meanwhile, State Program Officer, Gagandeep Singh revealed that Hepatitis-C treatment was being provided in 22 districts hospitals and three medical colleges in the state, with the existing staff of medical specialists, lab technicians and pharmacists being leveraged for Hepatitis C care delivery.
He also said that till mid-July, 31,000 Hepatitis C patients had been treated in the state with a success rate of 93 per cent.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.